IRIS
COSTA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.560
AS - Asia 1.183
EU - Europa 1.027
SA - Sud America 170
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.507
SG - Singapore 493
CN - Cina 400
IT - Italia 201
SE - Svezia 199
IE - Irlanda 189
BR - Brasile 137
DE - Germania 109
HK - Hong Kong 90
FI - Finlandia 79
VN - Vietnam 62
TR - Turchia 57
NL - Olanda 45
ZA - Sudafrica 40
FR - Francia 39
CA - Canada 37
AT - Austria 29
GB - Regno Unito 29
IN - India 19
CZ - Repubblica Ceca 17
RU - Federazione Russa 17
AR - Argentina 15
PL - Polonia 13
ES - Italia 12
BD - Bangladesh 11
LT - Lituania 11
RO - Romania 11
BE - Belgio 10
CI - Costa d'Avorio 10
JP - Giappone 10
MX - Messico 8
PY - Paraguay 5
ID - Indonesia 4
IL - Israele 4
KH - Cambogia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
IQ - Iraq 3
KE - Kenya 3
KR - Corea 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
MA - Marocco 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
SC - Seychelles 2
SM - San Marino 2
SN - Senegal 2
UA - Ucraina 2
AL - Albania 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.008
Salva come PNG Salva come JPEG
Città #
Singapore 239
Ashburn 237
Chandler 218
Dublin 188
Santa Clara 115
Parma 98
Hong Kong 90
Dallas 83
Beijing 82
Ann Arbor 74
New York 66
Shanghai 58
Dearborn 54
Boardman 46
Munich 40
Izmir 38
Johannesburg 38
Nanjing 36
Los Angeles 35
Princeton 32
Ho Chi Minh City 28
Vienna 24
Helsinki 23
Shenyang 23
Toronto 20
Wilmington 20
Marseille 18
Columbus 17
Turku 17
Hanoi 14
Jinan 14
Kunming 14
Moscow 14
Bremen 13
Council Bluffs 13
Hebei 13
Kocaeli 13
Nanchang 13
Brno 12
Milan 11
Warsaw 11
Abidjan 10
Brussels 10
Chicago 10
Jiaxing 10
San Mateo 10
Frankfurt am Main 9
Redmond 9
Tokyo 9
Brooklyn 8
Buffalo 8
Focsani 8
Hefei 8
Montreal 8
The Dalles 8
Tianjin 8
Zhengzhou 8
Changsha 7
Denver 7
Stockholm 7
Woodbridge 7
Düsseldorf 6
Hangzhou 6
London 6
Modena 6
Orem 6
Poplar 6
São Paulo 6
Chongqing 5
Fairfield 5
Houston 5
Ottawa 5
Palermo 5
Phoenix 5
Belo Horizonte 4
Boston 4
Chennai 4
Des Moines 4
Jakarta 4
Madrid 4
Norwalk 4
Phnom Penh 4
Rio Saliceto 4
Rio de Janeiro 4
Rome 4
Salvador 4
San Jose 4
Seattle 4
Torino 4
Ahmedabad 3
Amsterdam 3
Ankara 3
Asunción 3
Atlanta 3
Contagem 3
Cuiabá 3
Gorgonzola 3
Lauterbourg 3
Manchester 3
Mauá 3
Totale 2.546
Salva come PNG Salva come JPEG
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 181
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 168
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 165
The Proteasome and Myeloma-Associated Bone Disease 164
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 157
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 147
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 141
Improved scaffold biocompatibility through anti-Fibronectin aptamer functionalization 136
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 136
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 134
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION 132
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 131
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 130
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 129
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 128
Oncolytic virotherapy and microenvironment in multiple myeloma 126
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma. 126
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 125
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 123
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 123
Possible targets to treat myeloma-related osteoclastogenesis 115
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 114
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 112
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 110
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 107
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 105
Il mieloma multiplo nell'era dei nuovi farmaci. Patogenesi 104
PD-L1/PD-1 axis in multiple myeloma microenvironment and a possible link with CD38-mediated immune-suppression 98
CD38: A target for immunotherapeutic approaches in multiple myeloma 94
Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14(+) Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis 92
Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis 87
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 84
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+ 62
Totale 4.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021136 0 0 0 0 0 6 9 15 40 28 9 29
2021/2022164 5 5 10 14 3 0 28 10 14 11 8 56
2022/2023805 90 93 64 70 63 86 29 49 223 7 22 9
2023/2024333 16 30 10 6 23 104 36 17 9 14 11 57
2024/2025942 15 39 41 107 103 94 53 47 125 70 92 156
2025/20261.064 189 136 220 171 265 83 0 0 0 0 0 0
Totale 4.086